Third Arc Bio
Highly Engaged Employees
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Philadelphia, Pennsylvania, 19002, Unite...Website
www.thirdarcbio.comRevenue
$5.6 MillionIndustry
About Third Arc Bio
Third Arc Bio Org Chart
Is Third Arc Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Third Arc Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Third Arc Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Third Arc Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Third Arc Bio launches new products
Check if Third Arc Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Third Arc Bio recently announced quarterly report
Check out if Third Arc Bio is spiking on competitors!
Click to see if Third Arc Bio had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Third Arc Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Third Arc Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Third Arc Bio.
Third Arc Bio financials insights
Gather financial insights about Third Arc Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$165M
Series A
$52M
Most Recent Scoops
Third Arc Bio News & Media
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
SAN DIEGO and SUZHOU, China and SPRING HOUSE, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) and Third Arc Bio, Inc. (“Third Arc Bio”), today announced a licensing agreement under which Third Arc Bio will utilize Adagene’s SAFEbody technology platform to generate masked CD3 T cell engagers against unique tumor associated antigens. Under the terms of the agreement, Third Arc Bio will receive rights to research, develop and commercialize two candidateThird Arc Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Lead T Cell Engager ARC101 to Treat CLDN6 Positive Cancers
-- ARC101 is the company's first bispecific antibody targeting Claudin 6 (CLDN6), optimized for best-in-class T cell engagement -- First-in-human study will evaluate the safety, tolerability, pharmacokinetics and antitumor activity of ARC101 in patients with advanced cancer SPRING HOUSE,...
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Third Arc Bio
Third Arc Bio is a clinical stage biotechnology company that designs multifunctional antibody medicines to modulate immune synapses in solid tumors and inflammatory disease, uniting discovery platforms and translational expertise to deliver transformative biologic therapies for patients.... Read More


